A Study to Evaluate the Safety, Tolerability, and Efficacy of A197 in Subjects With Dry Eye Disease
Clinical trial NCT05238597 · COMPLETED
Trial details
- NCT number
- NCT05238597
- Sponsor
- Aramis Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-25
- Primary completion
- 2023-01-24
- Enrollment
- 207
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.